Rutgers New Jersey Medical School is home to some of the most advanced biomedical research facilities around. The efforts of our forward-thinking scientists, who are respected international leaders in their respective fields, hold the promise of tomorrow’s new treatments and drugs that have the potential to either save or improve the lives of the infirmed.

As an academic health center, most of New Jersey Medical School’s funding comes from the National Institutes of Health, which supports research on biomedical problems through highly competitive peer-review.  Over the last several years, NJMS researchers have brought in more than $150 million in grant support from the NIH, which includes individual investigator grants, program project grants as well as equipment and infrastructure grants.

NJMS’ areas of research excellence span a variety of fields and include: cardiovascular disease, infection and immunity, and neuroscience. In these areas, a substantial number of NJMS scientists publish their findings in high impact biomedical research journals, including Cell, New England Journal of Medicine, and Nature Medicine. NJMS’ state-of-the-art research core facilities are utilized not only by NJMS researchers, but by others in the community, including scientists in biotechnology and pharmaceutical industries. 

NJMS is an economic engine of growth, attracting new companies in the biomedical health arena to the city of Newark to work with NJMS faculty and staff and to utilize our outstanding facilities. Indeed, as a biomedical research facility, NJMS is a true New Jersey jewel.


Congratulatory remarks from Rutgers University President, Jonathan Holloway,
for the remarkable research led by the Institute of Infectious and Inflammatory Diseases I3D